Lion's Mane

1. What conditions has Lion's Mane been studied for?

• Cognition, mood, and mental health: Reviews describe reported improvements in cognitive function, anxiety, and depression, and summarize human studies on neurocognition and mood (with Lion’s Mane being the most studied mushroom in intervention trials).

• Neuroprotection / neuroregeneration: Polysaccharide-focused reviews describe neuroprotection and neuroregeneration as key bioactivities; a cell study isolated compounds that increased NGF and also increased BDNF and synaptic markers in vitro.

• Neurodegenerative disease prevention (dietary context): A “brain-diets” review lists Lion’s Mane among emerging foods for brain health, while emphasizing the need for rigorous clinical evidence.

• Cancer-related outcomes (preclinical): A murine colon carcinoma model (CT-26) evaluated Lion’s Mane extracts for anti-metastatic effects (lung metastasis inhibition) and apoptosis in cancer cells.

• Metabolic and cardiovascular-related outcomes (mostly preclinical/reviewed): Reviews report study areas including antidiabetic/anti-hyperglycemia, anti-hyperlipidemia, and antihypertensive effects.

• Gastrointestinal: Reviews describe anti-gastric ulcer activity and “nourishing the stomach” traditional use.

• Immune/inflammation/oxidative stress: Reviews repeatedly attribute broad effects to anti-inflammatory, antioxidative, and immunostimulating/immunomodulatory properties.

• Fatigue/aging-related outcomes: Reviews list anti-fatigue, anti-aging/anti-senescence as studied areas.

• “Stacking” with psilocybin microdosing (observational): Two large naturalistic studies examined combining psilocybin microdoses with Lion’s Mane (and sometimes niacin) for mood/mental health and psychomotor outcomes.

2. Does it work in treating those conditions? Summarize the evidence.

• Cognition and mood (humans): mixed but suggestive. A systematic review of human epidemiological and clinical studies found epidemiological studies (diet patterns including mushrooms of any species) generally associated with better cognition/mood, but intervention trials were mixed. The intervention studies “mainly investigated Lion’s Mane,” showing some enhancement of mood and cognitive function in middle-aged and older adults, but the review explicitly calls for more adequately powered, well-designed trials with sensitive testing.

• Neurotrophic mechanisms (cells): supportive mechanistic evidence, not proof of clinical benefit. Isolated Lion’s Mane constituents (e.g., isohericerinol A, corallocin A, hericerin) increased NGF production in C6 glioma cells and promoted neurite outgrowth in neuronal cells; protein expression of NGF, BDNF, and synaptophysin increased in a co-culture model. This supports plausibility for “memory improvement,” but remains in vitro evidence.

• Cancer/metastasis (animals/cells): promising preclinical results. In a CT-26 murine colon carcinoma model, hot water and 50% ethanol extracts induced apoptosis in cancer cells and reduced lung metastasis signals (e.g., reduced MMP-2/MMP-9, u-PA, and MAPK pathway phosphorylation). Dietary administration reduced lung tumor nodules by about ~50–55% in that model. This is encouraging but not human clinical evidence.

• Metabolic, GI, cardiovascular, fatigue/aging claims: largely review-level and preclinical. The provided abstracts are primarily narrative/systematic reviews summarizing multiple reported activities (antidiabetic, antihyperlipidemic, anti-ulcer, etc.) without presenting specific human trial outcomes in the excerpts shown. Based on these abstracts alone, efficacy for these indications in humans remains unconfirmed.

• Psilocybin microdosing “stack” (humans, observational): Lion’s Mane did not clearly add mood benefit. In a ~30-day naturalistic observational study, psilocybin microdosers showed small-to-medium improvements in mood/mental health versus comparators, but combining psilocybin with Lion’s Mane and vitamin B3 did not impact mood/mental health changes. However, in older microdosers, the combination (psilocybin + Lion’s Mane + B3) was associated with psychomotor improvements relative to some other regimens. Because this is observational, it cannot establish causality.

Overall, the abstracts support that Lion’s Mane has biological plausibility (neurotrophic/anti-inflammatory/antioxidant mechanisms) and some human signals for mood/cognition, but the clinical evidence base described here is limited and mixed, with stronger findings in preclinical models than in definitive human trials.

3. What health benefits does it have?

• Potential cognitive and mood support: Human intervention literature summarized in a systematic review suggests some enhancement of mood and cognitive function in middle-aged and older adults, though results are mixed and more rigorous trials are needed.

• Neurotrophic support (mechanistic): Specific compounds from Lion’s Mane fruiting bodies increased NGF production and supported neurite outgrowth in cell models; increased expression of BDNF and synaptophysin was also reported in vitro.

• Anti-inflammatory, antioxidative, and immunomodulatory activity: Multiple reviews attribute many reported benefits to these properties across cells/animals/humans, and highlight polysaccharides (e.g., β-glucans) as key bioactive components.

• Potential cardiometabolic benefits (mostly preclinical/reviewed): Reviews list antihyperlipidemic, antihypertensive, and antihyperglycemic/antidiabetic activities as reported properties.

• Gastroprotective potential: Polysaccharide reviews describe anti-gastric ulcer activity.

• Anticancer/antimetastatic potential (preclinical): In a mouse model, certain extracts reduced lung metastasis-related outcomes and tumor nodules, associated with reduced MMPs and related signaling.

• Nutritional/functional food value: A metabolomics study compared multiple mushroom species (including Lion’s Mane) and quantified amino acids including L-ergothioneine, a dietary antioxidant candidate found in mushrooms (the excerpt does not provide Lion’s Mane-specific quantities, but supports mushrooms as sources of diverse metabolites).

4. Does it have any downsides or side effects?

The provided abstracts contain very limited direct safety/side-effect reporting for Lion’s Mane specifically. Key limitations from these excerpts:

• Human safety data not detailed here: The reviews emphasize benefits and mechanisms but do not provide side-effect rates, contraindications, or adverse event summaries in the text shown.

• Observational “stacking” studies do not establish safety of Lion’s Mane: The microdosing studies focus on psilocybin microdosing practices and outcomes; they note that adding Lion’s Mane did not change mood outcomes and may relate to psychomotor outcomes in older adults, but they do not provide Lion’s Mane-specific adverse event conclusions in the excerpts shown.

• General evidence limitation: Because much of the cited efficacy evidence is preclinical (cells/animals) or review-level, the risk–benefit profile in specific patient groups (e.g., pregnancy, autoimmune disease, people on anticoagulants, etc.) cannot be determined from these abstracts alone.

Bottom line from the provided material: no clear downsides/side effects are documented in these excerpts, but the absence of reported harms here should not be interpreted as proof of safety; it mainly reflects that safety details are not included in the supplied abstracts.

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

The provided abstracts do not report pharmacogenomic findings for Lion’s Mane (e.g., effects modified by specific genetic variants, or genotype-based dosing/safety considerations).

• No gene–supplement interactions described: None of the excerpts mention genetic polymorphisms (such as CYP variants, inflammatory pathway variants, APOE status, etc.) influencing response or risk.

• Implication: Based on these abstracts alone, there is insufficient evidence to claim Lion’s Mane is beneficial or harmful for any specific genetic variation.

References

1. Medicinal Mushrooms: Their Bioactive Components, Nutritional Value and Application in Functional Food Production-A Review.
   Paulina Łysakowska, Aldona Sobota, Anna Wirkijowska (2023) - Molecules (Basel, Switzerland)
2. Chemistry, Nutrition, and Health-Promoting Properties of Hericium erinaceus (Lion's Mane) Mushroom Fruiting Bodies and Mycelia and Their Bioactive Compounds.
   Mendel Friedman (2015) - Journal of agricultural and food chemistry
3. Structures, biological activities, and industrial applications of the polysaccharides from Hericium erinaceus (Lion's Mane) mushroom: A review.
   Xirui He, Xiaoxiao Wang, Jiacheng Fang, Yu Chang, Ning Ning, Hao Guo, Linhong Huang, Xiaoqiang Huang, Zefeng Zhao (2017) - International journal of biological macromolecules
4. Therapeutic Potential of
   Pit Shan Chong, Man-Lung Fung, Kah Hui Wong, Lee Wei Lim (2019) - International journal of molecular sciences
5. Enriching the Mediterranean diet could nourish the brain more effectively.
   Pasquale Picone, Antonella Girgenti, Miriam Buttacavoli, Domenico Nuzzo (2024) - Frontiers in nutrition
6. Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers.
   Joseph M Rootman, Pamela Kryskow, Kalin Harvey, Paul Stamets, Eesmyal Santos-Brault, Kim P C Kuypers, Vince Polito, Francoise Bourzat, Zach Walsh (2021) - Scientific reports
7. Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls.
   Joseph M Rootman, Maggie Kiraga, Pamela Kryskow, Kalin Harvey, Paul Stamets, Eesmyal Santos-Brault, Kim P C Kuypers, Zach Walsh (2022) - Scientific reports
8. Metabolomics Profiling of White Button, Crimini, Portabella, Lion's Mane, Maitake, Oyster, and Shiitake Mushrooms Using Untargeted Metabolomics and Targeted Amino Acid Analysis.
   Cassi N Uffelman, Katrina A Doenges, Michael L Armstrong, Kevin Quinn, Richard M Reisdorph, Minghua Tang, Nancy F Krebs, Nichole A Reisdorph, Wayne W Campbell (2023) - Foods (Basel, Switzerland)
9. A review of the effects of mushrooms on mood and neurocognitive health across the lifespan.
   Sara Cha, Lynne Bell, Barbara Shukitt-Hale, Claire M Williams (2024) - Neuroscience and biobehavioral reviews
10. Hericium erinaceus: an edible mushroom with medicinal values.
    Md Asaduzzaman Khan, Mousumi Tania, Rui Liu, Mohammad Mijanur Rahman (2013) - Journal of complementary & integrative medicine
11. The effects of twenty-one nutrients and phytonutrients on cognitive function: A narrative review.
    John E Lewis, Jillian Poles, Delaney P Shaw, Elisa Karhu, Sher Ali Khan, Annabel E Lyons, Susana Barreiro Sacco, H Reginald McDaniel (2021) - Journal of clinical and translational research
12. Hericium erinaceus (Lion's Mane) mushroom extracts inhibit metastasis of cancer cells to the lung in CT-26 colon cancer-tansplanted mice.
    Sung Phil Kim, Seok Hyun Nam, Mendel Friedman (2013) - Journal of agricultural and food chemistry
13. Neurotrophic isoindolinones from the fruiting bodies of Hericium erinaceus.
    Se Hwan Ryu, Seong Min Hong, Zahra Khan, Seul Ki Lee, Manjunatha Vishwanath, Ayman Turk, Sang Won Yeon, Yang Hee Jo, Dae Hee Lee, Jae Kang Lee, Bang Yeon Hwang, Jae-Kyung Jung, Sun Yeou Kim, Mi Kyeong Lee (2021) - Bioorganic & medicinal chemistry letters
14. The Addition of Reishi and Lion's Mane Mushroom Powder to Pasta Influences the Content of Bioactive Compounds and the Antioxidant, Potential Anti-Inflammatory, and Anticancer Properties of Pasta.
    Magdalena Szydłowska-Tutaj, Urszula Szymanowska, Krzysztof Tutaj, Dorota Domagała, Urszula Złotek (2023) - Antioxidants (Basel, Switzerland)
15. The Role of Dietary Ingredients in Mental Energy - A Scoping Review of Randomized Controlled Trials.
    Kristin M Nieman, Yong Zhu, Michelle Tucker, Katie Koecher (2024) - Journal of the American Nutrition Association
16. Over the Counter Supplements for Memory: A Review of Available Evidence.
    Haley Hersant, Sean He, Peter Maliha, George Grossberg (2023) - CNS drugs
17. Neurotrophic properties of the Lion's mane medicinal mushroom, Hericium erinaceus (Higher Basidiomycetes) from Malaysia.
    Puei-Lene Lai, Murali Naidu, Vikineswary Sabaratnam, Kah-Hui Wong, Rosie Pamela David, Umah Rani Kuppusamy, Noorlidah Abdullah, Sri Nurestri A Malek (2013) - International journal of medicinal mushrooms
18. Characterization of α-glucosidase inhibitory constituents of the fruiting body of lion's mane mushroom (Hericium erinaceus).
    Seul Ki Lee, Se Hwan Ryu, Ayman Turk, Sang Won Yeon, Yang Hee Jo, Yoo Kyong Han, Bang Yeon Hwang, Ki Yong Lee, Mi Kyeong Lee (2020) - Journal of ethnopharmacology
19. Isolation and Evaluation of Erinacine A Contents in Mycelia ofHericium erinaceusStrains
    Mengchen Liu, Liangliang Liu, Xiaoya Song, Yingjun Zhou, Yuande Peng (2024)
20. In vitro anti-Helicobacter pylori effects of medicinal mushroom extracts, with special emphasis on the Lion's Mane mushroom, Hericium erinaceus (higher Basidiomycetes).
    Xiaodong Shang, Qi Tan, Ruina Liu, Kangying Yu, Pingzuo Li, Guo-Ping Zhao (2013) - International journal of medicinal mushrooms